Companies could be overstating their pension liabilities by up to £60bn due to their life expectancy assumptions, according to XPS Pensions Group.
Two in five UK defined benefit (DB) schemes expect to complete a bulk annuity or longevity swap transaction within the next three years, Willis Towers Watson research finds.
Darryl Brundle and Ashley Kanter look at the contrasting pressures and easements on longevity associated with the pandemic
While the CMI Model of longevity improvements has proved reliable, Covid-19 threatens to cause it to show an unrealistic falls in life expectancy. Tim Gordon explains why the industry should not overreact
Just a fraction of liability growth since the start of the year will be offset by the impact of excess deaths caused by Covid-19, says Lane Clark & Peacock (LCP).
A scheme vulnerability analysis tool aiming to allow pension schemes to understand the likely impact of Covid-19 on their members’ life expectancy has been launched by XPS Pensions Group.
Nikhil Patel looks at how schemes have hedged longevity over the last decade, and how this will develop in the future.
Pension schemes and life insurers should be prepared for a modest change to their assumptions for mortality rates in the post-Covid-19 world, an academic study suggests.
After a bumper year, insurers are now facing a slower and smaller pipeline as schemes grapple with Covid-19, writes James Phillips.
The number of deaths registered in the UK in the week ending Friday 10 April (week 15) was 77% higher than expected if using the same standardised mortality rates as 2019, says the Continuous Mortality Investigation (CMI).
Very few schemes have protection in place against longevity risk in their scheme liabilities. Howard Kearns explains why and how to rectify this
Three Lloyds Banking Group pension schemes have transferred £10bn of longevity risk to Pacific Life Re in the second-largest longevity swap ever.
Schemes are increasingly looking at longevity hedging as part of their de-risking process, according to a survey by Insight Investment.
Zurich has agreed to insure £800m of longevity risk for the pensioners of a FTSE 100-sponsored pension scheme.
There are a wide range of possible life expectancy disruptors. PwC's Paul Kitson looks at how one of these, wearables, could impact schemes.
Pension schemes face higher liabilities as improvements in mortality rates trend towards their highest level in a decade.
Everyone thinks they know their age, but the number of times we cirlce the sun may not be the most accurate measure. James Phillips looks at emerging science and the impact on retirement policy.
British people born between 2016 and 2018 are expected to live up to 4.2 weeks longer than those born in the 2015-17 period, according to the Office for National Statistics (ONS).
The Centre for Social Justice has proposed raising the state pension age to 75 by 2035, despite a slowdown in mortality improvements. Holly Roach reports
This week's top stories included HSBC's scheme completing a £7bn longevity swap with PICA and the government announcing it would review the tapered allowance for NHS scheme members.
Around £17.5bn of buy-ins and buyouts were transacted in the first half of the year as market records continue to tumble.
Following Rolls-Royce's record buyout earlier this month, James Phillips speaks to some of the key players about the process.
People retiring in the UK will on average outlive their pension savings by 10 years, according to research by the World Economic Forum (WEF).
A parliamentary group has been set up to introduce a national strategy which focuses on the benefits of longevity, rather than the "problems" of an ageing UK population.